Sum Up The Pieces: BBMC Could Be Worth $113
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 24 2024
0mins
Should l Buy FN?
Source: NASDAQ.COM
ETF Analysis: The JPMorgan BetaBuilders US Mid Cap Equity ETF (BBMC) has an implied analyst target price of $113.44, indicating a potential upside of 16.47% from its current trading price of $97.40.
Stock Performance Insights: Notable underlying holdings such as Hillenbrand Inc, Life Time Group Holdings Inc, and Fabrinet show significant upside potential based on analyst target prices, raising questions about the validity and optimism of these targets in light of recent market developments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FN
Wall Street analysts forecast FN stock price to rise
6 Analyst Rating
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 543.020
Low
499.00
Averages
544.83
High
600.00
Current: 543.020
Low
499.00
Averages
544.83
High
600.00
About FN
Fabrinet is a provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, automotive components, industrial lasers, medical devices and sensors. The Company offers a range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly and testing. It focuses primarily on low-volume production of a wide variety of high complexity products. It also designs and fabricates applications-specific crystals, lenses, prisms, mirrors, laser components, and substrates (customized optics) and other custom and standard borosilicate, clear fused quartz, and synthetic fused silica glass products (customized glass).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analyst Optimistic on Cloud and AI Infrastructure Growth
- Cloud Spending Surge: The analyst noted that companies like Arista and Ciena are poised to benefit from rising hyperscale cloud spending as AI infrastructure expands, particularly with Microsoft's significant increase in cloud expenditures in 2025.
- Arista's AI Revenue Target Increase: Arista raised its 2026 AI revenue target from $2.75 billion to $3.25 billion, indicating its potential expansion in AI networking, especially with Jericho products playing a crucial role in large-scale networking projects.
- Ciena's Market Share: In Q1 of fiscal 2026, direct cloud providers accounted for 42% of Ciena's revenue, and the company has secured partnerships for large-scale networking projects with three of the four major cloud operators, highlighting its key role in connecting AI data centers.
- Strong Demand for Optical Components: Companies like Lumentum, Applied Optoelectronics, and Coherent are expected to benefit from strong demand for optical components, with Lumentum generating 50% of its revenue from datacom products and having a backlog exceeding $400 million for optical circuit switching systems.
See More
Fabrinet to Host Investor Q&A Sessions at OFC Conference
- Investor Engagement: Fabrinet will host two investor and analyst Q&A sessions on March 17, 2026, at the Optical Fiber Communication Conference in Los Angeles, scheduled from 3:00 to 3:45 PM PT and 4:00 to 4:45 PM PT, aimed at enhancing communication and transparency with investors.
- Live Webcast: The Q&A sessions will be accessible via live webcast and replay on Fabrinet's investor website, further improving the accessibility of company information and fostering investor understanding of the company's strategy.
- Company Overview: Fabrinet is a leading provider of optical packaging and precision electro-mechanical manufacturing services, focusing on complex products such as optical communication components, automotive parts, and medical devices, showcasing its expertise in high-complexity production.
- Global Resource Network: Fabrinet maintains engineering and manufacturing resources in Thailand, the USA, China, and Israel, enabling it to support diverse production needs and ensuring competitiveness and flexibility in the global market.
See More
VTWO ETF 52-Week Price Analysis
- Price Range Analysis: The VTWO ETF has a 52-week low of $69.38 and a high of $109.76, with the latest trade at $99.17, indicating relative stability and investor confidence in the current market.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment and potential buying opportunities.
- ETF Unit Trading Mechanism: ETFs trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on investor demand, impacting the underlying asset allocation of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding helps identify ETFs experiencing notable inflows (new units created) or outflows (old units destroyed), allowing for assessment of their impact on underlying holdings.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Share Increase: Rice Hall James & Associates acquired 574,877 shares of QuidelOrtho in Q4 2026, reflecting confidence in the company's future prospects despite a 43.4% decline in stock price over the past year.
- Investment Value: This acquisition raised QuidelOrtho's stake to 1.3% of the fund's 13F reportable assets, indicating recognition of its potential value, which may attract further investor interest.
- Market Performance: As of February 13, 2026, QuidelOrtho's market capitalization stood at $1.6 billion with a current price of $23.58, trailing the S&P 500 by 55.2 percentage points, highlighting competitive pressures in the market.
- Strategic Adjustments: QuidelOrtho is undergoing strategic adjustments, including strengthening its product pipeline and improving spending returns, with analysts expecting these efforts to yield modest revenue and operating profit growth in the coming years.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Increased Holdings: Rice Hall James purchased 574,877 shares of QuidelOrtho in Q4, raising its total stake to 833,791 shares valued at $23.8 million, reflecting a positive outlook on the company's future prospects.
- Investment Value Growth: The position's value increased by $16.2 million at quarter-end, indicating a rise in stock price and additional share purchases, suggesting the fund's optimistic view on QuidelOrtho's potential value.
- Industry Position: As a leader in in vitro diagnostics, QuidelOrtho has struggled with consistent revenue growth and profitability in recent years, but its strategic adjustments and strengthened product pipeline may improve financial performance, attracting value investors.
- Market Expectations: Analysts expect QuidelOrtho to achieve modest revenue and operating profit growth in the coming years, although the Motley Fool analyst team did not include it in their list of top investment stocks, indicating a divergence in market perceptions of its potential.
See More
Rice Hall James Increases Stake in Stride by 122,430 Shares
- Share Increase: Rice Hall James & Associates, LLC increased its stake in Stride by 122,430 shares in Q4 2026, bringing its ownership to 1.5%, indicating confidence in Stride's future growth potential.
- Market Value Fluctuation: Despite the increase, Stride's quarter-end market value fell by $17.7 million, reflecting the impact of stock price movements and additional shares, suggesting market concerns about its short-term performance.
- Earnings Outlook: During Stride's Q4 earnings call, management reaffirmed full-year revenue guidance while raising adjusted operating income expectations, indicating that the market's negative reaction may have been overstated, presenting a potential undervaluation opportunity.
- Market Performance: Stride's stock price has dropped 39.5% over the past year and underperformed the S&P 500 by 51.2 percentage points, highlighting challenges in the education market but also providing potential buying opportunities for investors.
See More
Analyst Optimistic on Cloud and AI Infrastructure Growth
- Cloud Spending Surge: The analyst noted that companies like Arista and Ciena are poised to benefit from rising hyperscale cloud spending as AI infrastructure expands, particularly with Microsoft's significant increase in cloud expenditures in 2025.
- Arista's AI Revenue Target Increase: Arista raised its 2026 AI revenue target from $2.75 billion to $3.25 billion, indicating its potential expansion in AI networking, especially with Jericho products playing a crucial role in large-scale networking projects.
- Ciena's Market Share: In Q1 of fiscal 2026, direct cloud providers accounted for 42% of Ciena's revenue, and the company has secured partnerships for large-scale networking projects with three of the four major cloud operators, highlighting its key role in connecting AI data centers.
- Strong Demand for Optical Components: Companies like Lumentum, Applied Optoelectronics, and Coherent are expected to benefit from strong demand for optical components, with Lumentum generating 50% of its revenue from datacom products and having a backlog exceeding $400 million for optical circuit switching systems.
See More
Fabrinet to Host Investor Q&A Sessions at OFC Conference
- Investor Engagement: Fabrinet will host two investor and analyst Q&A sessions on March 17, 2026, at the Optical Fiber Communication Conference in Los Angeles, scheduled from 3:00 to 3:45 PM PT and 4:00 to 4:45 PM PT, aimed at enhancing communication and transparency with investors.
- Live Webcast: The Q&A sessions will be accessible via live webcast and replay on Fabrinet's investor website, further improving the accessibility of company information and fostering investor understanding of the company's strategy.
- Company Overview: Fabrinet is a leading provider of optical packaging and precision electro-mechanical manufacturing services, focusing on complex products such as optical communication components, automotive parts, and medical devices, showcasing its expertise in high-complexity production.
- Global Resource Network: Fabrinet maintains engineering and manufacturing resources in Thailand, the USA, China, and Israel, enabling it to support diverse production needs and ensuring competitiveness and flexibility in the global market.
See More
VTWO ETF 52-Week Price Analysis
- Price Range Analysis: The VTWO ETF has a 52-week low of $69.38 and a high of $109.76, with the latest trade at $99.17, indicating relative stability and investor confidence in the current market.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment and potential buying opportunities.
- ETF Unit Trading Mechanism: ETFs trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on investor demand, impacting the underlying asset allocation of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding helps identify ETFs experiencing notable inflows (new units created) or outflows (old units destroyed), allowing for assessment of their impact on underlying holdings.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Share Increase: Rice Hall James & Associates acquired 574,877 shares of QuidelOrtho in Q4 2026, reflecting confidence in the company's future prospects despite a 43.4% decline in stock price over the past year.
- Investment Value: This acquisition raised QuidelOrtho's stake to 1.3% of the fund's 13F reportable assets, indicating recognition of its potential value, which may attract further investor interest.
- Market Performance: As of February 13, 2026, QuidelOrtho's market capitalization stood at $1.6 billion with a current price of $23.58, trailing the S&P 500 by 55.2 percentage points, highlighting competitive pressures in the market.
- Strategic Adjustments: QuidelOrtho is undergoing strategic adjustments, including strengthening its product pipeline and improving spending returns, with analysts expecting these efforts to yield modest revenue and operating profit growth in the coming years.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Increased Holdings: Rice Hall James purchased 574,877 shares of QuidelOrtho in Q4, raising its total stake to 833,791 shares valued at $23.8 million, reflecting a positive outlook on the company's future prospects.
- Investment Value Growth: The position's value increased by $16.2 million at quarter-end, indicating a rise in stock price and additional share purchases, suggesting the fund's optimistic view on QuidelOrtho's potential value.
- Industry Position: As a leader in in vitro diagnostics, QuidelOrtho has struggled with consistent revenue growth and profitability in recent years, but its strategic adjustments and strengthened product pipeline may improve financial performance, attracting value investors.
- Market Expectations: Analysts expect QuidelOrtho to achieve modest revenue and operating profit growth in the coming years, although the Motley Fool analyst team did not include it in their list of top investment stocks, indicating a divergence in market perceptions of its potential.
See More
Rice Hall James Increases Stake in Stride by 122,430 Shares
- Share Increase: Rice Hall James & Associates, LLC increased its stake in Stride by 122,430 shares in Q4 2026, bringing its ownership to 1.5%, indicating confidence in Stride's future growth potential.
- Market Value Fluctuation: Despite the increase, Stride's quarter-end market value fell by $17.7 million, reflecting the impact of stock price movements and additional shares, suggesting market concerns about its short-term performance.
- Earnings Outlook: During Stride's Q4 earnings call, management reaffirmed full-year revenue guidance while raising adjusted operating income expectations, indicating that the market's negative reaction may have been overstated, presenting a potential undervaluation opportunity.
- Market Performance: Stride's stock price has dropped 39.5% over the past year and underperformed the S&P 500 by 51.2 percentage points, highlighting challenges in the education market but also providing potential buying opportunities for investors.
See More
